The LAM Foundation urgently seeks safe and effective treatments, and ultimately a cure, for lymphangioleiomyomatosis (LAM) through advocacy and the funding of promising research. It is dedicated to serving the scientific, medical, and patient communities by providing information, resources, and a worldwide network of hope and support. Founded in 1995, the Foundation focuses on supporting women with LAM and their families, engaging the medical and scientific community, and raising funds for research.
The Pilot and Feasibility Grant program offered by The LAM Foundation aims to support the development and testing of new hypotheses and/or methods in research areas relevant to LAM, a rare and progressive lung disease. The grant encourages innovative approaches to important questions in LAM research or the development of novel methods. It necessitates that the proposed work be either hypothesis-generating or hypothesis-testing, backed by sufficient preliminary data to merit the Foundation's support. The goal is for results from these grants to facilitate the submission of applications for further funding from other agencies, such as the NIH. Funding can go up to $50,000 for a period of up to 1 year.